Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Autophagy Induction After Bortezomib for Myeloma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetic Profile of CKD-581
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
- Status
- COMPLETED
- Phase
- PHASE1
Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Imaging Studies and the Development of Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Telomerase Activity as a Marker For Mobilization Quality
- Status
- UNKNOWN
- Phase
- N/A